Coreva Scientific GmbH & Co KG
Scott joins Coreva as health economist.
#Infection after #surgery is a major issue, hampering patient recovery and costing healthcare systems millions. Right now, there is even more strain on budgets and a huge reason (#covid19) to get patients out of hospital asap. Want to know how #hospitals could invest to benefit themselves and patients? Read our latest manuscript: Sternal-Wound Infections following..Read more
What is the role of HTA for medical devices in European market access? find out more about it on our Coreva Scientific GmbH & Co. KG.‘s Linkedin page here or on our twitter page here.
Interested in the emerging evidence on vitamin D’s role in reducing Covid-19 severity? Coreva Scientific GmbH & Co. KG.‘s Dr Sita Saunders and Amanda Hansson Hedblom offer their view on our Linkedin page in this article: Can vitamin D boost your immune system and your mood in the fight against..Read more
Amanda joins Coreva as HEOR and Market Access associate.
Is capsule endoscopy a cost-effective strategy for Crohn’s disease management in England? Coreva’s Rafael and Rhodri explored this interesting question in collaboration with key British gastroenterologists, using our previously developed capsule endoscopy model re-fitted to match the NHS treatment pathways. Please see our publication page.
Natalie joins Coreva as Team assistant. In addition to being native in German and Russian, and proficient in English and Italian, she brings with her excellent administrative, teamwork and communication skills. She acquired these skills from long-term management experience in the service sector. She will also contribute with her health..Read more
Coreva Scientific are pleased to announce the publication of our latest paper on optimizing obesity care. It’s open access, research as it should be. https://rdcu.be/b3pQa
Improved bariatric surgery pathways could reduce health care burden, costs in Canada. Coreva Scientific are featured in MDalert (Reuters Health), following Coreva Scientific’s recent publication in JAMA Network Open that can be found on our publication page.
Over the course of 2019 we are proud to have worked on over 35 projects that covered 16 medical products and 21 countries. Evidence has been presented in 5 published manuscripts, 14 abstracts, and 12 posters and congress presentations. Thanks to everyone for your support!
December also hosted our annual Coreva Scientific team-building event; a very productive two days that will help restructure the company for new challenges
Our article, a “Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices” was published in Frontiers in Medicine. Please see our publication page.
Out this month in Clinical and Experimental Gastroenterology, our manuscript on “Evaluating the clinical and economic consequences of using video capsule endoscopy to monitor Crohn’s disease”. https://doi.org/10.2147/CEG.S198958
It was our pleasure to welcome Audrey from DaVinci Healthcare Group to our office. A great day of strategy planning for our upcoming project was completed by dinner out in the local vineyards.
Coreva is now on Twitter. Don’t miss our latest Tweets and follow us at https://twitter.com/CorevaHEOR.
Congress month, with oral presentations on economic evaluation of medical devices at HTAi (Köln, Germany) and the burden of surgical-site infections in Europe at EHMA (Espoo, Finland). We also presented a research poster on a public-private collaboration to objectively measure the value of capnography monitoring at EHMA.
At ISPOR we presented our poster on “Economic evaluation of medical devices: are there lessons to be learnt from Europe?” Take a look at it http://www.coreva-scientific.com/wp-content/uploads/2019/05/ISPOR-New-Orleans-MD-HTA_final.pdf
Sita joins our team as a project leader.
We look forward to hosting you in our new offices situated at the foot of the Siebengebirge national park and on the bank of the river Rhine. Located in the greater Bonn area, we are easily accessible from Bonn, Cologne, and Frankfurt.
Over the course of 2018 we are proud to have worked on over 30 projects that covered 14 medical products and 18 countries. Evidence has been presented in 3 published manuscripts, 9 abstracts, 7 posters and congress presentations. Thanks to everyone for your support!